iShares IXJ ETF (ASX:IXJ)
The iShares IXJ ETF provides investors with a targeted exposure to over 100 global healthcare companies. This includes companies in the pharmaceutical, biotechnology, and medical device space.
What does the IXJ invest in?
IXJ invests in a portfolio of global healthcare companies, including leading brands like Johnson & Johnson, CSL and Glaxosmithkline. Trying to replicate this exposure to healthcare stocks yourself would be time-consuming and expensive, so IXJ could be a solution for investors looking for a targeted exposure to this sector.
What do investors use IXJ for?
IXJ could be used by investors to gain a tactical exposure to the global healthcare sector, and has a strong geographical exposure to the US market. This ETF aims to track the S&P Global 1200 Healthcare Sector Index, before fees and expenses.
IXJ dividend information
Best ETFs warnings
The following warnings are applied by our team, based on quantitative metrics and our internal methodology. These risks are not exhaustive and therefore they should not be relied upon. Always read the PDS of the function and speak to your financial adviser before acting on this information.
Looking for something better?
This brilliant (and free!) report is issued by Best ETFs Australia, a division of The Rask Group Pty Ltd. It is not a recommendation.
Speak to a financial professional before relying on this information and please read our Financial Services Guide (FSG).